OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
Siyao Deng, Tijana Vlatkovic, Moying Li, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4874-4874
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

New Horizons in Lung Cancer Management Through ATR/CHK1 Pathway Modulation
Riya Thapa, Obaid Afzal, Asif Ahmad Bhat, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1807-1818
Open Access | Times Cited: 47

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Jinze Shen, Qurui Wang, Yunan Mao, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25

PARP inhibitors combined with radiotherapy: are we ready?
Chen Sun, Alan Chu, Rui Song, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
Xueqin Huang, Li You, Eugenie Nepovimová, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15

FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis
Hong Zhou, Yanxia Wang, Min Wu, et al.
The Journal of Pathology (2024) Vol. 262, Iss. 4, pp. 427-440
Closed Access | Times Cited: 5

The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 5

Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer
Yijun Xie, Di Xiao, Duo Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access

Targeting the AURKB-MAD2L2 Axis Disrupts the DNA Damage Response and Glycolysis to Inhibit Colorectal Cancer Progression
Shengjie Li, Jiayou Ye, K C Yang, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 2
Open Access

Unveiling radiobiological traits and therapeutic responses of BRAFV600E-mutant colorectal cancer via patient-derived organoids
Peiyuan Mu, Shaobo Mo, Xingfeng He, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

The influence of the microbiome on radiotherapy and DNA damage responses
Aadil Sheikh, Michael A. Curran
Frontiers in Oncology (2025) Vol. 15
Open Access

Prognostic gene expression profile of colorectal cancer
Mohamed J. Saadh, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, et al.
Gene (2025), pp. 149433-149433
Closed Access

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
María San Román, Javier Torres-Jiménez, Javier Pozas, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 863-863
Open Access | Times Cited: 10

Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)
I. Rivero Belenchón, Carmen Belen Congregado Ruiz, Carmen Sáez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12978-12978
Open Access | Times Cited: 10

Gene expression signature predicts radiation sensitivity in cell lines using the integral of dose–response curve
Alona Kolnohuz, Leyla Ebrahimpour, Sevinj Yolchuyeva, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

DNA Double-Strand Break Repair Kinetics after Exposure to Photons and Ions: A Systematic Review
Wilhelmina E. Radstake, Alessio Parisi, Janet M. Denbeigh, et al.
Radiation Research (2024) Vol. 201, Iss. 6
Closed Access | Times Cited: 3

Glycyrrhizin ameliorates colorectal cancer progression by regulating NHEJ pathway through inhibiting HMGB1-induced DNA damage response
Yu‐Hui Han, Wenjiong Sheng, Xiuxin Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation
Yuying Huang, Licheng Li, Zhongmin Kang, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 2

Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors
Philipp Demuth, Lea Thibol, Anna Lemsch, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3441-3441
Open Access | Times Cited: 2

Targeting TRIP13 for overcoming anticancer drug resistance (Review)
Liwen Zhao, Siyu Ye, Shengnan Jing, et al.
Oncology Reports (2023) Vol. 50, Iss. 5
Open Access | Times Cited: 6

Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
Yidian Wang, Shou‐Ye Hu, Weisong Zhang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6

A perspective on tumor radiation resistance following high-LET radiation treatment
Yogendra S. Rajpurohit, Dhirendra Kumar Sharma, Mitu Lal, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy
Xueying Wang, Haoyu Zhang, XinZhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top